Jan Willem Greve, MD, PhD

Bariatric / Metabolic Surgeon, Heerlen, Netherlands

Greve serves as medical director of the Dutch Obesity Clinics South and chair of the Metabolic and Bariatric Surgery Unit at the Zuyderland Medical Center in the Netherlands. Greve received his PhD at the Academic Hospital in Maastricht, Netherlands, has served on numerous committees, supervised 15 doctoral theses and authored more than 185 peer-reviewed papers and numerous book chapters on intensive care medicine, nutrition and bariatric and metabolic surgery. He was principal investigator of two European EndoBarrier clinical trials and other single-center and multicenter studies.

“Obesity and its co-morbidities are an immense challenge for modern health care,” said Greve. “Bariatric or metabolic surgery is a proven tool to treat morbidly obese patients with type 2 diabetes. However, the majority of these patients may have a BMI that is too low or have serious contraindications that preclude them from being candidates for such an invasive surgical procedure. As a bariatric / metabolic surgeon, I believe EndoBarrier is a powerful addition to our treatment armamentarium.”

<< Back to Scientific Advisory Board